The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates

Based on the findings from the Phase III clinical trials of inactivated SARS COV-2 Vaccine, (BBIBP-CORV) emergency use authorization (EUA) was granted for the vaccine to frontline workers in the UAE. A prospective cohort study was conducted among frontline workers to estimate the incidence rate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Kaabi, Nawal, Oulhaj, Abderrahim, Al Hosani, Farida Ismail, Al Mazrouei, Shamma, Najim, Omer, Hussein, Salah Eldin, Abdalla, Jehad Saleh, Fasihuddin, Mohammed Saifuddin, Hassan, Afnan Abdellatif, Elghazali, Gehad, Al Rumaithi, Ahmed, Al Azazi, Jumana, Weber, Stefan, Beiram, Rami, Parekh, Khatija A., Sheek-Hussein, Mohamud, Yang, Yunkai, Xiaoming, Yang, Quliang, Jenny, Eltantawy, Islam, Mahmoud, Sally, Koshy, Ashish, Xiao, Peng, Ganesan, Subhashini, Elamin, Wael, Zaher, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752587/
https://www.ncbi.nlm.nih.gov/pubmed/35017530
http://dx.doi.org/10.1038/s41598-021-04244-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752587/
https://www.ncbi.nlm.nih.gov/pubmed/35017530
http://dx.doi.org/10.1038/s41598-021-04244-1

Ejemplares similares